Genzyme Corporation (Nasdaq: GENZ) today announced that the European Commission has approved Renvela® (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback